Eylea Treatment for Macular Degeneration

A new drug has been developed as a treatment for macular degeneration.  The drug named Eylea will compete directly with Lucentis, the current leading treatment for the eye disease. It is expected … [Read more...]

Gene Based Macular Degeneration Treatment Promising

A new gene based treatment for wet macular degeneration has showed promise after being administered to 18 patients as part of an ongoing study. Developed by Oxford Biomedica, RetinoStat targets … [Read more...]

New Brunswick Covers Lucentis Treatments for Wet Macular Degeneration

Lucentis, the leading treatment for the eye disease wet macular degeneration is now covered through the New Brunswick Prescription Drug Plan (NBPDP).  The November 16 announcement ensures that people … [Read more...]

Eye Drops for Dry Macular Degeneration?

A topical eye drop treatment for dry macular degeneration may be one step closer to reality after MacuCLEAR's drug MC-1101 and Mystic Pharmaceuticals VersiDoser phase 1b clinical trial showed … [Read more...]

Avastin as Effective as Lucentis for Macular Degeneration

Avastin as effective as Lucentis for treating macular degeneration.  Researchers have shown that there is no difference between Avastin and Lucentis when used to treat macular degeneration. Avastin … [Read more...]